31 – 40 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
- Contribution to journal › Article
- 2022
-
Mark
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
- Contribution to journal › Article
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
- Contribution to journal › Article
-
Mark
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population : A Multicenter Study
- Contribution to journal › Article
-
Mark
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
- Contribution to journal › Article
-
Mark
Risk of Gynecological Cancers in Cholecystectomized Women : A Large Nationwide Cohort Study
- Contribution to journal › Article
-
Mark
Luteolin, a Potent Anticancer Compound : From Chemistry to Cellular Interactions and Synergetic Perspectives
- Contribution to journal › Scientific review
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
- Contribution to journal › Article
-
Mark
Hubbing the cancer cell
- Contribution to journal › Scientific review
-
Mark
Comment on Russo et al. Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Cancers 2022, 14, 2465
- Contribution to journal › Letter
